Journal of Peking University(Health Sciences) ›› 2015, Vol. 47 ›› Issue (4): 728-731. doi: 10.3969/j.issn.1671-167X.2015.04.036

• Articles • Previous Articles    

Progress in diagnosis and treatment of adrenal metastases tumor

WU Chu-jun, QIU Min△, MA Lu-lin   

  1. (Department of Urology, Peking University Third Hospital, Beijing 100191, China)
  • Online:2015-08-18 Published:2015-08-18
  • Contact: QIU Min E-mail:qm1868@sina.com

Abstract:

The adrenal gland is a common site of metastases, only second to pulmonary, liver and bone. The prevalence of adrenal metastases in patients with a history of cancer is between 10%-25%.The most common sites of origin are cancers of the lung, kidney, breast, gastrointestinal tract, and skin (melanoma).The mainstays of adrenal metastases diagnosis are computerized tomogramphy (CT), magnetic resonance imaging (MRI), and positron emission tomogramphy (PET). All patients should undergo complete hormonal evaluation to rule out functional adrenal tumors. Adrenal biopsy should be reserved for cases in which the results of non-invasive techniques are equivocal. In patients with isolated adrenal metastases, adrenalectomy is recommended, because of improved overall survival. For the patient with unresectable adrenal metastases tumor, radiotherapy and ablative therapy are feasible and useful methods for controlling adrenal metastases and offer patients opportunities for improved survival.

Key words: Adrenal gland neoplasms, Neoplasm metastasis, Diagnosis, Therapy

CLC Number: 

  • R736.6
[1] Jiale GAO, Zhongtao ZHANG. Current status and future perspectives of precision treatment for locally advanced rectal cancer [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 247-250.
[2] Hai WANG, Yizhou JIANG. Molecular mechanisms and clinical applications of anti-angiogenic therapy in precision treatment of breast cancer [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 251-256.
[3] Hao FU, Luyan SHEN, Bingyang HUANG, Shaohua MA. Clinical strategies for perioperative management of esophageal squamous cell carcinoma in the immunotherapy era [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 266-271.
[4] Jialin LI, Liqiao CHEN, Jiatian TANG, Yan WU, Anqiang WANG. Conversion therapy for hepatoid adenocarcinoma of the stomach: A case report [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 399-404.
[5] Zichen PAN, Kai CHEN, Yukun HOU, Bohan YANG, Jixin ZHANG, Yongsu MA, Xiaodong TIAN, Yinmo YANG. Research progress in clinical pathology and molecular mechanisms of pancreatic adenosquamous carcinoma [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 431-435.
[6] Ye ZHAO, Xiaoli DIAO, Yan XIONG. Application of cell transfer technology in pathological diagnosis of micro-volume cell fluid [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 208-213.
[7] Yue WANG, Yuhong LIANG. Florid cemento-osseous dysplasia: A case report [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 220-224.
[8] Yanting CHI, Hongjie JIANG, Yan CHEN, Zhixiu XU, Binbin LI. Value of direct immunofluorescence in the diagnosis of oral mucosal pemphigus vulgaris: A retrospective study based on multi-index combined analysis [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 68-73.
[9] Jingyan GU, Xinyi LI, Jinxia ZHAO, Rong MU. Diabetic Charcot neuroarthropathy initially misdiagnosed as rheumatoid arthritis and gout: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1193-1197.
[10] Xiaodi XIAO, Youchen XIA, Jianying LIU, Peng FU. Left sided sternocleidomastoid interosseous intravascular papillary endothelial hyperplasia: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 1002-1004.
[11] Xiangyu SUN, Chao YUAN, Xinzhu ZHOU, Jing DIAO, Shuguo ZHENG. Application of salivary micro-ecosystem in early prevention and control of oral and systemic diseases [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 859-863.
[12] Zhemin LI, Jiafu JI, Guoxin LI, Ziyu LI, Zhaode BU, Xiangyu GAO, Di DONG, Lei TANG, Xiaofang XING, Shuqin JIA, Ting GUO, Lianhai ZHANG, Fei SHAN, Xin JI, Anqiang WANG. Development and dissemination of precision medicine approaches in gastric cancer management [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 864-867.
[13] Yuanjie NIU, Zhongcheng XIN, Guiting LIN, Pan DING, Jiancheng PAN, Yuhong FENG, Yinglu GUO. Low-level laser therapy for the treatment of male infertility and erectile dysfunction [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 627-632.
[14] Wanwei HUANG, Xianshen SHA, Yibao ZHANG, Guohao WU, Feng LUO, Zhihui CHEN, Dongming YE, Xuesong LI, Caiyong LAI. Total 3D laparoscopic ileal ureters replacement for bilateral ureters combined with bladder augmentation in the management of post-radiotherapy bilateral ureteral strictures and contracted bladder [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 789-795.
[15] Qiushi XU, Tong LIU, Junjie WANG. Ferroptosis-related long non-coding RNA to predict the clinical outcome of non-small cell lung cancer after radiotherapy [J]. Journal of Peking University (Health Sciences), 2025, 57(3): 569-577.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!